Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Nfkbiz 3′ UTR Mutations Confer Selective Growth Advantage and Affect Drug Response in Diffuse Large B-Cell Lymphoma

Sarah E Arthur, BSc, Nicole Thomas, BSc, Christopher Rushton, BSc, Jeffrey Tang, Miguel Alcaide, PhD, Shannon Healy, PhD, Adele Telenius, Anja Mottok, MD PhD, David W. Scott, MBChB, PhD, Christian Steidl, MD, Ryan D Morin, PhDBSc,MSc

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-137700

Published: 2020

Journal Articles

Diffuse Large B-Cell Lymphomas with a Molecular PMBCL Expression Signature Represent a Distinct Molecular Subtype Associated with Poor Clinical Outcome

Gerben Duns, PhD, Elena Viganò, PhD, Daisuke Ennishi, MD PhD, Clementine Sarkozy, MD, Stacy Hung, Elizabeth Chavez, Katsuyoshi Takata, MD PhD, Anja Mottok, MD PhD, Randy D. Gascoyne, MD, Ryan D. Morin, PhD, Kerry J Savage, BSc, MD MSc, David W. Scott, MBChB, PhD, Christian Steidl, MD

Blood (2019) 134 (Supplement_1): 922.

https://doi.org/10.1182/blood-2019-131450

Published: 2019

Journal Articles

Mutational Landscape of Grey Zone Lymphoma

Blood (2019) 134 (Supplement_1): 21.

https://doi.org/10.1182/blood-2019-127375

Published: 2019

Journal Articles

Single Cell Transcriptome Analysis Reveals Disease-Defining T Cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma

Blood (2019) 134 (Supplement_1): 547.

https://doi.org/10.1182/blood-2019-121584

Published: 2019

Journal Articles

NFKBIZ 3′ UTR Mutations Confer Selective Growth Advantage and Activate Genes with Therapeutic Implications in Diffuse Large B-Cell Lymphoma

Sarah E Arthur, BSc, Nicole Thomas, BSc, Christopher Rushton, BSc, Miguel Alcaide, PhD, Shannon Healy, PhD, Anja Mottok, MD PhD, David W. Scott, MBChB, PhD, Christian Steidl, MD, Ryan D. Morin, PhD

Blood (2019) 134 (Supplement_1): 296.

https://doi.org/10.1182/blood-2019-127421

Published: 2019

Journal Articles

TP53 Expression Correlates with TP53 Mutations and Is an Independent Predictor of Clinical Outcome in Patients with DLBCL Treated with R-CHOP

Pedro Farinha, MD PhD, Daisuke Ennishi, MD PhD, Anja Mottok, MD PhD, Susana Ben-Neriah, BSc, Barbara Meissner, PhD, Merrill Boyle, BSc, Jeffrey W. Craig, MD PhD, Graham W Slack, MD, Diego Villa, MD MPH, Kerry J Savage, BSc, MD MSc, Laurie H Sehn, MD, Ryan D. Morin, PhD, Marco A. Marra, PhD, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Christian Steidl, MD, David W. Scott, MBChB, PhD

Blood (2019) 134 (Supplement_1): 3964.

https://doi.org/10.1182/blood-2019-121943

Published: 2019

Journal Articles

PRAME Expression Is Correlated with Treatment Outcome and Specific Features of the Tumor Microenvironment in Classical Hodgkin Lymphoma

Katsuyoshi Takata, MD PhD, Lauren C. Chong, MSc, Avinash Thakur, PhD, Tomohiro Aoki, MD PhD, Anja Mottok, MD PhD, Elizabeth Chavez, BSc, Cg RT, Pedro Farinha, MD PhD, Graham W Slack, MD, Pamela Hoodles, Sohrab P Shah, David W. Scott, MBChB, PhD, Christian Steidl, MD

Blood (2019) 134 (Supplement_1): 1509.

https://doi.org/10.1182/blood-2019-129730

Published: 2019

Journal Articles

Functional Investigation of the Gene NFKBIZ and the Impact of 3'UTR Mutations in Diffuse Large B-Cell Lymphoma

Sarah E Arthur, BSc, Anja Mottok, MD PhD, Miguel Alcaide, PhD, Christopher Rushton, BSc, Bruno M. Grande, BSc, Daisuke Ennishi, MDPhD, Jordan Davidson, BSc, Kevin R Bushell, BSc, MSc, Randy D. Gascoyne, MD, Marco A Marra, PhD, Joseph M Connors, MD, Gregg B Morin, PhD, David W. Scott, MD PhD FRACP, FRCPA, Christian Steidl, MD, Ryan D. Morin, PhDBSc,MSc

Blood (2017) 130 (Supplement 1): 1228.

https://doi.org/10.1182/blood.V130.Suppl_1.1228.1228

Published: 2017

Journal Articles

Deciphering Discordance between MYC mRNA and MYC IHC in DLBCL: The Role of MYC Exon 2 Mutations and N11S Polymorphism

Blood (2017) 130 (Supplement 1): 3994.

https://doi.org/10.1182/blood.V130.Suppl_1.3994.3994

Published: 2017

Journal Articles

RAL Mediates Multiple Myeloma Cell Survival Independently of Oncogenic RAS

Marcel Seibold, Thorsten Stuehmer, Nadine Kremer, Anja Mottok, MD PhD, Claus J Scholz, Daniela Bruennert, Manik Chatterjee, Ellen Leich, Andreas Schlosser, Andreas Rosenwald, Hermann Einsele, Ralf C Bargou, Torsten Steinbrunn

Blood (2017) 130 (Supplement 1): 4406.

https://doi.org/10.1182/blood.V130.Suppl_1.4406.4406

Published: 2017

Journal Articles

Comprehensive MYC and BCL2 Genetic Profiling in De Novo Diffuse Large B-Cell Lymphoma Demonstrates Clinically Relevant Genetic Alterations According to Cell of Origin Subtype

Daisuke Ennishi, MD PhD, Anja Mottok, MD, Kerry J. Savage, MDMSc, Susana Ben-Neriah, Hennady Shulha, Pedro Farinha, MD, Fong Chun Chan, MSc, Barbara Meissner, Merrill Boyle, BSc, Christoffer E Hother, MD PhD, Robert Kridel, MD MPH, Ryan Morin, PhD, Marco A Marra, PhD, Laurie H. Sehn, Christian Steidl, MD, Joseph M. Connors, MD, David W Scott, MBChB, PhD, Randy D. Gascoyne

Blood (2015) 126 (23): 109.

https://doi.org/10.1182/blood.V126.23.109.109

Published: 2015

Journal Articles

Genetic Alterations of Gα13 Signaling Pathway with BCL2 over-Expression Confers Lymphoma Dissemination and Inferior Outcome in Germinal Center B Cell Diffuse Large B Cell Lymphoma

Daisuke Ennishi, MD PhD, Anja Mottok, MD, Hennady Shulha, Pedro Farinha, MD, Fong Chun Chan, MSc, Barbara Meissner, Merrill Boyle, BSc, Susana Ben-Neriah, Christoffer E Hother, MD PhD, Robert Kridel, MD MPH, Ryan Morin, PhD, Marco A Marra, PhD, Kerry J. Savage, MDMSc, Laurie H. Sehn, Joseph M. Connors, MD, Christian Steidl, MD, David W Scott, MBChB, PhD, Randy D. Gascoyne

Blood (2015) 126 (23): 111.

https://doi.org/10.1182/blood.V126.23.111.111

Published: 2015

Journal Articles

Flow Cytometric Characterization of 129 Cases of Peripheral T Cell Lymphoma Not Otherwise Specified (PTCL NOS) and Angioimmunoblastic T Cell Lymphoma (AITL)

Greg Hapgood, MD, Anja Mottok, MD, Graham W Slack, MD, Randy D. Gascoyne, Christian Steidl, MD, Kerry J. Savage, MDMSc, Andrew P. Weng, MD PhD

Blood (2015) 126 (23): 2667.

https://doi.org/10.1182/blood.V126.23.2667.2667

Published: 2015

Journal Articles

Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from Childhood and Adolescent Hodgkin Lymphoma Patients

Anja Mottok, MD, Rebecca Lea Johnston, Fong Chun Chan, MSc, David W Scott, MBChB, PhD, Debra L. Friedman, MD MS, Cindy Schwartz, MD, Kara M. Kelly, MD, Terzah M. Horton, MD PhD, Christian Steidl, MD

Blood (2015) 126 (23): 175.

https://doi.org/10.1182/blood.V126.23.175.175

Published: 2015

Journal Articles

Clinical Significance of Genetic Aberrations in Diffuse Large B Cell Lymphoma

Daisuke Ennishi, MD PhD, Christoffer Hoffer, Hennady Shulha, Anja Mottok, MD, Pedro Farinha, MD, Fong Chun Chan, MSc, Barbara Meissner, PhD, Merrill Boyle, B.Sc., Susana Ben-Neriah, MSc, Ryan D Morin, PhD, Marco A. Marra, PhD, Kerry J. Savage, MDMSc, Laurie H. Sehn, MDMPH, Joseph M Connors, MD, Christian Steidl, MD, David W. Scott, MBChB, PhD, Randy D. Gascoyne, MD

Blood (2014) 124 (21): 703.

https://doi.org/10.1182/blood.V124.21.703.703

Published: 2014

Journal Articles

The Impact of Concurrent MYC BCL2 Protein Expression on the Risk of Secondary Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma (DLBCL)

Kerry J. Savage, MDMSc, Laurie H. Sehn, MDMPH, Diego Villa, MDMPH, Roopesh R. Kansara, MD, Anja Mottok, MD, Daisuke Ennishi, MDPhD, Susana Ben-Neriah, MSc, Robert Kridel, MDMPH,, Christian Steidl, MD, King L. Tan, MBBS, Nathalie Johnson, MDPhD, Graham W. Slack, MD, Joseph M. Connors, MD, Pedro Farinha, MD, David W. Scott, MBChB, PhD, Randy D. Gascoyne, MD

Blood (2014) 124 (21): 495.

https://doi.org/10.1182/blood.V124.21.495.495

Published: 2014

Journal Articles

Genetic Alterations of the MHC Class II Transactivator CIITA Are Frequent in Primary Mediastinal Large B-Cell Lymphoma and Associated with Diminished MHC Class II Expression

Anja Mottok, MD, Bruce W. Woolcock, MSc, Fong Chun Chan, MSc, Adele Telenius, MSc, Elizabeth A. Chavez, Cg R.T, Merrill Boyle, B.Sc., Susana Ben-Neriah, MSc, Lisa M. Rimsza, MD, Reiner Siebert, MD, Randy D. Gascoyne, MD, Christian Steidl, MD

Blood (2014) 124 (21): 3040.

https://doi.org/10.1182/blood.V124.21.3040.3040

Published: 2014

Journal Articles

Cell-of-Origin Assignment in Diffuse Large B-Cell Lymphoma Determined By Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Has Prognostic Significance Independent of IPI and MYC/BCL2 Immunohistochemistry

David W. Scott, MBChB, PhD, Anja Mottok, MD, Daisuke Ennishi, MD PhD, George W. Wright, PhD, Pedro Farinha, MD, Susana Ben-Neriah, MSc, Robert Kridel, MD MPH, Garrett S Barry, B.Sc, Christoffer E Hother, MDPhD, Kerry J. Savage, MDMSc, Laurie H. Sehn, MDMPH, Louis M. Staudt, Joseph M. Connors, MD, Lisa M. Rimsza, MD, Randy D. Gascoyne, MD

Blood (2014) 124 (21): 1624.

https://doi.org/10.1182/blood.V124.21.1624.1624

Published: 2014

Journal Articles

Analysis of Relapse Biopsies in Classical Hodgkin Lymphoma Reveals Correlations with Outcome after Autologous Stem Cell Transplantation

Fong Chun Chan, MSc, Anja Mottok, MD, Alina S. Gerrie, MD MPH, Maryse M. Power, MD MRCPI, FRCPath, Kerry J. Savage, MDMSc, Joseph M. Connors, Randy D. Gascoyne, MD, Sohrab P. Shah, PhD, David W. Scott, MBChB, PhD, Christian Steidl, MD

Blood (2014) 124 (21): 136.

https://doi.org/10.1182/blood.V124.21.136.136

Published: 2014

Journal Articles

Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project

Blood (2013) 122 (21): 73.

https://doi.org/10.1182/blood.V122.21.73.73

Published: 2013

NARROW

Nfkbiz 3′ UTR Mutations Confer Selective Growth Advantage and Affect Drug Response in Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lymphomas with a Molecular PMBCL Expression Signature Represent a Distinct Molecular Subtype Associated with Poor Clinical Outcome

Mutational Landscape of Grey Zone Lymphoma

Single Cell Transcriptome Analysis Reveals Disease-Defining T Cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma

NFKBIZ 3′ UTR Mutations Confer Selective Growth Advantage and Activate Genes with Therapeutic Implications in Diffuse Large B-Cell Lymphoma

TP53 Expression Correlates with TP53 Mutations and Is an Independent Predictor of Clinical Outcome in Patients with DLBCL Treated with R-CHOP

PRAME Expression Is Correlated with Treatment Outcome and Specific Features of the Tumor Microenvironment in Classical Hodgkin Lymphoma

Functional Investigation of the Gene NFKBIZ and the Impact of 3'UTR Mutations in Diffuse Large B-Cell Lymphoma

Deciphering Discordance between MYC mRNA and MYC IHC in DLBCL: The Role of MYC Exon 2 Mutations and N11S Polymorphism

RAL Mediates Multiple Myeloma Cell Survival Independently of Oncogenic RAS

Comprehensive MYC and BCL2 Genetic Profiling in De Novo Diffuse Large B-Cell Lymphoma Demonstrates Clinically Relevant Genetic Alterations According to Cell of Origin Subtype

Genetic Alterations of Gα13 Signaling Pathway with BCL2 over-Expression Confers Lymphoma Dissemination and Inferior Outcome in Germinal Center B Cell Diffuse Large B Cell Lymphoma

Flow Cytometric Characterization of 129 Cases of Peripheral T Cell Lymphoma Not Otherwise Specified (PTCL NOS) and Angioimmunoblastic T Cell Lymphoma (AITL)

Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from Childhood and Adolescent Hodgkin Lymphoma Patients

Clinical Significance of Genetic Aberrations in Diffuse Large B Cell Lymphoma

The Impact of Concurrent MYC BCL2 Protein Expression on the Risk of Secondary Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma (DLBCL)

Genetic Alterations of the MHC Class II Transactivator CIITA Are Frequent in Primary Mediastinal Large B-Cell Lymphoma and Associated with Diminished MHC Class II Expression

Cell-of-Origin Assignment in Diffuse Large B-Cell Lymphoma Determined By Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Has Prognostic Significance Independent of IPI and MYC/BCL2 Immunohistochemistry

Analysis of Relapse Biopsies in Classical Hodgkin Lymphoma Reveals Correlations with Outcome after Autologous Stem Cell Transplantation

Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only